Subsequently, using CRISPR/Cas9 gene editing to individually knockout Xkr8 or TMEM16F and, we show that both PS scramblases directly contribute to immune regulation and tumor growth in immune-competent mice but not NOD/SCID or RAG immune-deficient mice. The gene discussed is XKR8; the disease is neoplasm.